Jpmorgan Chase & Co »

Forte Biosciences shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Forte Biosciences shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $17 3 5.67

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Forte Biosciences

BVF
Perceptive Advisors
Fred Alger Management
BML Capital Management
Geode Capital Management
Susquehanna International
BlackRock
Group One Trading
Bank of America Corporation
Advisor Group Holdings
Bnp Paribas Arbitrage, Snc
Loring Wolcott Coolidge Fa
Jpmorgan Chase & Co
Barclays

View all funds holding Forte Biosciences